title: Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
authors.forename: K N
authors.initials: KN
authors.lastname: Fountoulakis
authors.forename: A
authors.initials: A
authors.lastname: Iacovides
authors.forename: M
authors.initials: M
authors.lastname: Siamouli
authors.forename: V
authors.initials: V
authors.lastname: Koumaris
authors.forename: G S
authors.initials: GS
authors.lastname: Kaprinis
mesh_terms: D000328:Adult; D000855:Anorexia / Q000188:drug therapy*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D000077152:Olanzapine; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D005473:Fluoxetine; D008803:Mianserin; D000078785:Mirtazapine; D000077152:Olanzapine; D017367:Selective Serotonin Reuptake Inhibitors